29 August - 1 September 2025

ESC Congress 2025 together with WCC - Madrid, Spain

We were pleased to be present at the ESC Congress and hope all participants had an inspiring and valuable experience.

Below, you'll find more information about the topics we presented during our symposium, including the critical role of home monitoring.

Atrial fibrillation is the most common sustained arrhythmia in women and men¹

Early detection of atrial fibrillation permits not only the management of the disease, but also the early treatment of comorbidities, the most common one being hypertension. A combined screening for both conditions is feasible and can improve the outcomes of patients2.

Monitoring blood pressure at home regularly helps detect changes early, this often before symptoms appear. This is an important step in preventing heart disease and managing conditions like hypertension and Atrial Fibrillation (AFib)3.

A Critical Window for Cardiovascular Health in Midlife Women

Blood Pressure, Menopause, and the Hidden Risk of Heart Failure

Emerging evidence underscores menopause as a pivotal transition in women’s cardiovascular health. The hormonal changes of menopause, especially the decline in estrogen, contribute to shifts in blood pressure regulation, vascular stiffness, and autonomic balance. These changes substantially increase the lifetime risk of heart failure with preserved ejection fraction (HFpEF) in postmenopausal women4.

The Blood Pressure Shift After Menopause

Studies consistently show that after menopause5:

- Systolic blood pressure rises more sharply in women than in men.

- Diastolic blood pressure may normalize or decline, masking early vascular dysfunction.

- Nocturnal hypertension and loss of dipping pattern become more prevalent.

From Hypertension to HFpEF

A Gendered Pathway

Unlike men, who more commonly develop heart failure with reduced ejection fraction (HFrEF), women, particularly postmenopausal, are disproportionately affected by HFpEF. The lifetime risk of HFpEF is nearly double that of HFrEF among women (10.7% vs 5.8%), whereas the lifetime risk of HFpEF and HFrEF are similar among men6.

Menopause is more than a reproductive milestone; it is a cardiovascular turning point. By identifying elevated blood pressure as an early modifiable risk, we can change the trajectory of heart failure in women.

Friday 29.08.2025 - 15.15 - 16.00

OMRON Symposium

Sex differences in heart failure risk factors and phenotype are increasingly recognized. Hypertension and obesity have emerged as particularly strong risk factors in women, and several female specific risk factors have been identified. Join our session to improve your knowledge on personalized prevention and management of heart failure in women.

Watch recording

Encourage Home BP Monitoring

A simple step to reduce cardiovascular risk

Home blood pressure monitoring (HBPM) is a practical, evidence-based way to detect early changes that in-office readings can mis, particularly in women aged 40+, with risk factors or perimenopausal symptoms.

Advise your patients to start HBPM if they:

- have fluctuating or borderline clinic BP

- have risk factors like obesity, diabetes, or family history

- are in perimenopause or post menopause

Read more about home monitoring

Related topics

Explore articles on hypertension, atrial fibrillation, and other cardiovascular diseases—and learn why starting screening at home can make a vital difference for your patients’ health.

Stroke Prevention in AFib Patients

Stroke prevention is a critical aspect of managing atrial fibrillation (AFib), a common cardiac arrhythmia that significantly increases the risk of ischaemic stroke. For healthcare professionals, early identification and effective prevention strategies are key to reducing the burden of stroke in these patients.

Read more about Stroke Prevention in AFib Patients

Recording of previous relevant webinars

More recordings

References

  1. Chugh SS et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-847.
  2. Gawałko M, Linz D. Atrial Fibrillation Detection and Management in Hypertension. Hypertension. 2023 Mar;80(3):523-533.
  3. Kario K. Home Blood Pressure Monitoring: Current Status and New Developments. Am J Hypertens. 2021 Aug 9;34(8):783-794.
  4. Adekunle AO, et al Predominance of Heart Failure With Preserved Ejection Fraction in Postmenopausal Women. Front Cell Dev Biol. 2021 Sep 29;9:685996.
  5. Maas AH, Franke HR. Women's health in menopause with a focus on hypertension. Neth Heart J. 2009 Feb;17(2):68-72.
  6. Borlaug BA, Sharma K, Shah SJ, Ho JE. Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement. J Am Coll Cardiol. 2023 May 9;81(18):1810-1834.
  7. Bordignon S, Chiara Corti M, Bilato C. Atrial Fibrillation Associated with Heart Failure, Stroke and Mortality. J Atr Fibrillation. 2012 Jun 15;5(1):467.
  8. Lei N, Kareem M, Moon SK, Ciaccio EJ, Acharya UR, Faust O. Hybrid Decision Support to Monitor Atrial Fibrillation for Stroke Prevention. Int J Environ Res Public Health. 2021 Jan 19;18(2):813.
  9. Gibbs H, et al. Clinical Outcomes in Asymptomatic and Symptomatic Atrial Fibrillation Presentations in GARFIELD-AF: Implications for AF Screening. Am J Med. 2021 Jul;134(7):893-901.e11.
Select a maximum of 2 products.